Below is a list of research protocols that have been reviewed and approved by the IRB, ensuring compliance with ethical standards and guidelines.
Reference No.
Protocol Title
Principal Investigator
Date of Submission
Date of Approval
Action
Ref. RMC/IRB/2025/21
Elevated Serum Ferritin is an Independent Predictor of Fibrosis among Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) – An Observational Study.
Professor Dr. Md Zahirul Haque
06 Sep, 2025
16 Sep, 2025
Ref. RMC/IRB/2025/20
Outcomes of STEMI between Diabetic and Non-Diabetic Patients After Streptokinase During Hospital Stay in a Tertiary Care Hospital.
Dr. Molla Md. Iftekhar Hossain
13 Sep, 2025
15 Sep, 2025
Ref. RMC/IRB/2025/21
Undergraduate Students’ Opinions and Acceptance of a Policy Requiring Mandatory Premarital Carrier Screening for Thalassemia in a Public University of Bangladesh.
Dr. Fardoushi Begum
28 Aug, 2025
15 Sep, 2025
Ref. RMC/IRB/2025/16
Carotid Intima-Media Thickness in Patients with Rheumatoid Arthritis Compared to Healthy Controls.
Dr. Uzzal Kumar Biswas
16 Jun, 2025
04 Sep, 2025
Ref. RMC/IRB/2025/17
Microalbuminuria in Rheumatoid Arthritis and It’s Correlation with Disease Activity.
Dr. Abida Sultana
03 Jun, 2025
04 Sep, 2025
Ref. RMC/IRB/2025/18
Evaluation of Clinical Outcomes of Primary Repair Using the Endorectal Advancement Flap for Complex Fistula in Ano.
Dr. Asim Sarkar
10 Jul, 2025
01 Sep, 2025
Ref. RMC/IRB/2025/19
Assessment of Arthropathy and Disability Burden in Bangladeshi Hemophilia Patients: An Observational Cross-Sectional study.
Dr. Marzia Afrin
17 Aug, 2025
01 Sep, 2025
Ref. RMC/IRB/2025/17
Comparative Evaluation of the Efficacy of Intra-Cervical Catheter (ICC) Versus Mifepristone in Termination of Intra-Uterine Fetal Death (IUFD) in Patients with a History of Previous Caesarean Section.
Dr. Sadafa Afrin
02 Jul, 2025
06 Aug, 2025
Ref. RMC/IRB/2025/16
Predictors of Postoperative Seroma Formation after Mastectomy for Breast Cancer.
Dr. M. S. M. Nazibur Rahman
14 Jun, 2025
09 Jul, 2025
Ref. RMC/IRB/2025/15
Comparative Study of External Beam Radiotherapy for Palliation of Symptoms in
Non-Small Cell Lung Cancer between 36 GY in 12 Fractions and 20 GY in 5 Fractions.